Clinical Trials Browser

Phase 2/3 × Interventional × Cardiotoxicity × Clear all

NCT04939857 2021-06-25

Effect of Trimetazidine on Radiotherapy-induced Heart Damage.

Phase 2/3 Unknown

Cardiotoxicity